COO at Redhill Biopharma Ltd. Sells $1,431 in Stock

Gilead Raday, who serves as COO at Redhill Biopharma Ltd. (RDHL), sold 14,310,000 shares of the company's stock, according to a disclosure filed with the U.S. Securities and Exchange Commission.

The total value of the transaction was approximately $1,431.

Insider transactions of this kind are publicly disclosed through Form 4 filings with the SEC, which must generally be submitted within two business days of the trade date.

Insider sales are common and can occur for reasons unrelated to a company's outlook, including scheduled trading plans, diversification, or personal financial planning.